SCV
Sands Capital Ventures Portfolio holdings
AUM
$508M
1-Year Return
48.12%
This Quarter Return
-15.02%
1 Year Return
+48.12%
3 Year Return
+324.3%
5 Year Return
–
10 Year Return
–
AUM
$409M
AUM Growth
-$50.8M
(-11%)
Cap. Flow
+$20.4M
Cap. Flow
% of AUM
4.99%
Top 10 Holdings %
Top 10 Hldgs %
90.46%
Holding
22
New
1
Increased
4
Reduced
7
Closed
2
Top Buys
| 1 |
BBNX
Beta Bionics, Inc. Common Stock
BBNX
|
+$38M |
| 2 |
Samsara
IOT
|
+$2.1M |
| 3 |
Datadog
DDOG
|
+$2M |
| 4 |
Nu Holdings
NU
|
+$1.47M |
| 5 |
monday.com
MNDY
|
+$396K |
Top Sells
| 1 |
UiPath
PATH
|
+$12.2M |
| 2 |
DoorDash
DASH
|
+$4.87M |
| 3 |
Coupang
CPNG
|
+$1.78M |
| 4 |
Snowflake
SNOW
|
+$1.78M |
| 5 |
Klaviyo
KVYO
|
+$822K |
Sector Composition
| 1 | Technology | 38.69% |
| 2 | Healthcare | 21.82% |
| 3 | Consumer Discretionary | 21.54% |
| 4 | Financials | 17.94% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Klaviyo
KVYO
$9.36B
| $104M | 25.48% |
3,443,515
-27,179
| -0.8% | -$822K |
|
|
2
Nu Holdings
NU
$75.8B
| $73.4M | 17.94% |
7,164,355
+143,196
| +2% | +$1.47M |
|
|
3
DoorDash
DASH
$110B
| $69.6M | 17.02% |
380,704
-26,639
| -7% | -$4.87M |
|
|
BBNX
4
Beta Bionics, Inc. Common Stock
BBNX
$1.15B
| $38M | 9.29% |
+3,103,782
| New | +$38M |
|
5
Inhibikase Therapeutics
IKT
$116M
| $24M | 5.86% |
10,950,000
| – | – |
|
|
6
Coupang
CPNG
$59.1B
| $18.5M | 4.52% |
843,476
-81,236
| -9% | -$1.78M |
|
|
7
monday.com
MNDY
$9.9B
| $12.1M | 2.97% |
49,908
+1,630
| +3% | +$396K |
|
|
8
Datadog
DDOG
$47.6B
| $11.7M | 2.86% |
117,930
+20,142
| +21% | +$2M |
|
|
9
Samsara
IOT
$21.9B
| $9.71M | 2.38% |
253,432
+54,742
| +28% | +$2.1M |
|
10
Tarsus Pharmaceuticals
TARS
$2.08B
| $8.73M | 2.14% |
170,000
| – | – |
|
11
Toast
TOST
$23.3B
| $6.99M | 1.71% |
210,611
-20,919
| -9% | -$694K |
|
12
CrowdStrike
CRWD
$109B
| $5.49M | 1.34% |
15,560
-1,540
| -9% | -$543K |
|
13
Acrivon Therapeutics
ACRV
$47.8M
| $4.31M | 1.05% |
2,122,605
| – | – |
|
14
10x Genomics
TXG
$1.57B
| $4.21M | 1.03% |
481,770
| – | – |
|
|
15
UiPath
PATH
$6.1B
| $4.08M | 1% |
395,855
-1,188,822
| -75% | -$12.2M |
|
|
16
Snowflake
SNOW
$74.9B
| $3.92M | 0.96% |
26,828
-12,179
| -31% | -$1.78M |
|
17
Acumen Pharmaceuticals
ABOS
$80M
| $3.76M | 0.92% |
3,417,075
| – | – |
|
|
BIOA
18
BioAge Labs, Inc. Common Stock
BIOA
$172M
| $2.96M | 0.72% |
786,353
| – | – |
|
19
Candel Therapeutics
CADL
$263M
| $2.29M | 0.56% |
405,837
| – | – |
|
20
Taysha Gene Therapies
TSHA
$837M
| $1.01M | 0.25% |
724,873
| – | – |
|
21
908 Devices
MASS
$202M
| – | – |
-237,258
| Closed | -$522K |
|
|
SPRB
22
DELISTED
Spruce Biosciences, Inc. Common Stock
SPRB
| – | – |
-715,817
| Closed | -$301K |
|